Telephone Consultation and Prescription in Pediatrics: Contributing Factors and Impact on Clinical Outcomes

Raymond N Haddad1, Celine Sakr2, Lydia Khabbaz2

  • 1Department of Pediatrics, Hotel Dieu de France University Medical Center, Saint Joseph University, Beirut, Lebanon.

Frontiers in Pediatrics
|February 4, 2020
PubMed

Insights

Phone consultations and prescriptions are common in pediatrics, despite restrictions. This practice leads to frequent prescription errors, necessitating pharmacist interventions and regulatory oversight for patient safety.

Area of Science:

  • Pediatric medicine
  • Telehealth
  • Pharmacology

Background:

  • Increasing global mobile phone ownership facilitates telehealth adoption.
  • Health professionals support telehealth for various healthcare delivery needs.
  • Concerns exist regarding the safety of phone-based medical practices in pediatrics due to regulatory restrictions.

Purpose of the Study:

  • To evaluate phone-based consultation and drug prescription patterns in pediatrics.
  • To identify factors influencing these practices and their impact on clinical outcomes.
  • To highlight the need for regulatory frameworks and stakeholder input.

Main Methods:

  • A national cross-sectional study over 5 months.
  • Data collected via self-administered questionnaires from pediatric-trained physicians.
  • Bivariate analysis used to assess factors influencing telephone prescriptions.

Main Results:

  • 90.8% of physicians prescribed drugs via phone (direct call, SMS, WhatsApp).
  • Antipyretics and cough suppressants were most frequently prescribed.
  • Pharmacists intervened in 40.4% of prescriptions; fever was linked to phone prescriptions.

Conclusions:

  • Phone-based consultations and prescriptions are prevalent in pediatric practices, even with restrictions.
  • Frequent medical prescription errors underscore the need for pharmacist interventions.
  • Current telemedicine practices prioritize convenience over patient safety, requiring regulatory oversight.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
186
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
195
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
147
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K